English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 107 | Tables: 102 | Agriculture
The global RNA Biopesticide market was valued at US$ 137 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 7.7% from 2026 to 2032.
RNA biopesticides are biological crop protection inputs whose active ingredient is a nucleic acid, most commonly dsRNA and in some cases short RNA formats, leveraging RNA interference (RNAi) and related mechanisms to silence essential genes in target pests or pathogens, thereby disrupting development or viability and enabling greener pest and disease control. Commercial pathways generally include plant-incorporated protectants (PIP), where crops express specific RNA for in-plant protection, and non-PIP products, where RNA actives are formulated for foliar spray and, in some cases, soil or chemigation delivery. Key upstream elements include nucleotide and enzyme or fermentation inputs for manufacturing (via in vitro transcription or fermentation-based expression), formulation carriers and adjuvant systems (encapsulation and controlled release, uptake enhancers, UV and rainfast stabilizers), QC analytics, and packaging and logistics solutions. Major downstream customers include crop protection companies and formulators, seed companies for PIP pathways, large growers and grower groups, ag input distributors and retailers, and selected public control programs. Applications span broadacre crops, orchards, and protected horticulture, often positioned within IPM programs and resistance-management rotations. On an ex-works manufacturing basis, gross margins typically fall in the 30% to 50% range, driven by production route, carrier system and QC standards, registered use patterns, and channel and service intensity.
The RNA biopesticide market is still transitioning from validation to scaled commercialization. Penetration remains limited, but strategic attention continues to rise, with clear regional differences and pathway divergence. Externally applied non-PIP products have begun to establish replicable registration and go-to-market frameworks in selected markets, moving from pilots toward broader crop and geographic adoption. In parallel, PIP pathways continue to advance at the pipeline level, while commercialization pace depends more on trait deployment and supporting agronomic systems. Current demand is concentrated in high-value crops, targets with elevated resistance pressure, and use cases where differentiated modes of action and improved environmental profiles are explicitly valued. The market is still driven by a relatively small number of leading programs, implying meaningful concentration at this stage.
From an industrialization and commercial logic perspective, the key question is not whether RNA can generate a biological effect, but whether it can deliver consistent field performance at an acceptable cost and fit within real-world crop protection programs. For non-PIP products, the core constraints center on delivery efficiency and environmental stability, as UV exposure, rainfall, and biological degradation can materially reduce persistence and consistency; therefore, carrier and adjuvant systems, formulation architecture, and application protocols often define practical performance boundaries. On the manufacturing side, developers must balance production routes against scalability, unit economics, purity and impurity-profile control, and lot-to-lot consistency, making supply capability and cost curve improvement decisive for commercialization pace. From a regulatory standpoint, novel modes of action typically come with more granular label conditions, and constraints on crops, targets, use frequency, and environmental requirements can directly shape how quickly and how broadly addressable market potential is unlocked.
Looking ahead, the most likely trajectory is faster commercialization of non-PIP spray products, accelerating engineering iteration in delivery and stabilization, and a shift from single-target launches toward programmatic use within integrated solutions. As early-market experience accumulates, additional products are likely to follow similar commercialization pathways, with emphasis remaining on insect targets and selected pathogen targets before expanding across broader crop systems. Delivery and formulation engineering will be a primary competitive axis, including systematic improvements in UV protection, rainfastness, and controlled-release persistence to improve field consistency while reducing effective dose and use complexity. On the demand side, RNA products are more likely to be positioned as rotation or complement tools within IPM and resistance management programs, forming combinations with conventional chemistry and other biologicals rather than replacing established programs in the near term.
Key drivers include rising resistance pressure and slower innovation cycles in conventional chemistries, stronger demand for low-residue and sustainability-aligned solutions, increasing attention to non-target and environmental risk profiles, and enabling advances in biomanufacturing and formulation science that support cost reduction and supply reliability. Constraints and risks are equally clear: field delivery and persistence remain the central technical bottleneck, and lack of repeatable performance will limit expansion across crops and geographies; scale-up, QC, and supply-chain ramp can pressure cost and delivery; regulatory heterogeneity, long timelines, and label constraints can slow commercialization; and channel education, grower practice adoption, and public perception can affect uptake. Overall, the market is likely to advance via a "few targets first, then broader crop and geography expansion" pathway, with medium-term outcomes hinging on delivery engineering, cost curves, and further clarification and convergence of regulatory pathways.
This report delivers a comprehensive overview of the global RNA Biopesticide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RNA Biopesticide. The RNA Biopesticide market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global RNA Biopesticide market comprehensively. Regional market sizes by Type, by Application, by Target Organism, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RNA Biopesticide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bayer
Corteva
Greenlight Biosciences
RNAissance Ag
Pebble Labs
Renaissance BioScience
Silicon Gene
Shanghai Plant Science Biotechnology
Xiaomo Biotech
Segment by Type
PIP
Non-PIP
Segment by Target Organism
Insect Pests
Nematodes and Mites
Pathogens
Other
Segment by Crop
Potatoes
Corn
Other
Segment by Application
Farmland
Orchard
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Target Organism, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for RNA Biopesticide companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Biopesticide Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 PIP
1.2.3 Non-PIP
1.3 Market by Target Organism
1.3.1 Global RNA Biopesticide Market Size Growth Rate by Target Organism: 2021 vs 2025 vs 2032
1.3.2 Insect Pests
1.3.3 Nematodes and Mites
1.3.4 Pathogens
1.3.5 Other
1.4 Market by Crop
1.4.1 Global RNA Biopesticide Market Size Growth Rate by Crop: 2021 vs 2025 vs 2032
1.4.2 Potatoes
1.4.3 Corn
1.4.4 Other
1.5 Market by Application
1.5.1 Global RNA Biopesticide Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Farmland
1.5.3 Orchard
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global RNA Biopesticide Market Perspective (2021–2032)
2.2 Global RNA Biopesticide Growth Trends by Region
2.2.1 Global RNA Biopesticide Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 RNA Biopesticide Historic Market Size by Region (2021–2026)
2.2.3 RNA Biopesticide Forecasted Market Size by Region (2027–2032)
2.3 RNA Biopesticide Market Dynamics
2.3.1 RNA Biopesticide Industry Trends
2.3.2 RNA Biopesticide Market Drivers
2.3.3 RNA Biopesticide Market Challenges
2.3.4 RNA Biopesticide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Biopesticide Players by Revenue
3.1.1 Global Top RNA Biopesticide Players by Revenue (2021–2026)
3.1.2 Global RNA Biopesticide Revenue Market Share by Players (2021–2026)
3.2 Global Top RNA Biopesticide Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by RNA Biopesticide Revenue
3.4 Global RNA Biopesticide Market Concentration Ratio
3.4.1 Global RNA Biopesticide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Biopesticide Revenue in 2025
3.5 Global Key Players of RNA Biopesticide Head Offices and Areas Served
3.6 Global Key Players of RNA Biopesticide, Products and Applications
3.7 Global Key Players of RNA Biopesticide, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 RNA Biopesticide Breakdown Data by Type
4.1 Global RNA Biopesticide Historic Market Size by Type (2021–2026)
4.2 Global RNA Biopesticide Forecasted Market Size by Type (2027–2032)
5 RNA Biopesticide Breakdown Data by Application
5.1 Global RNA Biopesticide Historic Market Size by Application (2021–2026)
5.2 Global RNA Biopesticide Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America RNA Biopesticide Market Size (2021–2032)
6.2 North America RNA Biopesticide Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America RNA Biopesticide Market Size by Country (2021–2026)
6.4 North America RNA Biopesticide Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Biopesticide Market Size (2021–2032)
7.2 Europe RNA Biopesticide Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe RNA Biopesticide Market Size by Country (2021–2026)
7.4 Europe RNA Biopesticide Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific RNA Biopesticide Market Size (2021–2032)
8.2 Asia-Pacific RNA Biopesticide Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific RNA Biopesticide Market Size by Region (2021–2026)
8.4 Asia-Pacific RNA Biopesticide Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America RNA Biopesticide Market Size (2021–2032)
9.2 Latin America RNA Biopesticide Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America RNA Biopesticide Market Size by Country (2021–2026)
9.4 Latin America RNA Biopesticide Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Biopesticide Market Size (2021–2032)
10.2 Middle East & Africa RNA Biopesticide Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa RNA Biopesticide Market Size by Country (2021–2026)
10.4 Middle East & Africa RNA Biopesticide Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer RNA Biopesticide Introduction
11.1.4 Bayer Revenue in RNA Biopesticide Business (2021–2026)
11.1.5 Bayer Recent Development
11.2 Corteva
11.2.1 Corteva Company Details
11.2.2 Corteva Business Overview
11.2.3 Corteva RNA Biopesticide Introduction
11.2.4 Corteva Revenue in RNA Biopesticide Business (2021–2026)
11.2.5 Corteva Recent Development
11.3 Greenlight Biosciences
11.3.1 Greenlight Biosciences Company Details
11.3.2 Greenlight Biosciences Business Overview
11.3.3 Greenlight Biosciences RNA Biopesticide Introduction
11.3.4 Greenlight Biosciences Revenue in RNA Biopesticide Business (2021–2026)
11.3.5 Greenlight Biosciences Recent Development
11.4 RNAissance Ag
11.4.1 RNAissance Ag Company Details
11.4.2 RNAissance Ag Business Overview
11.4.3 RNAissance Ag RNA Biopesticide Introduction
11.4.4 RNAissance Ag Revenue in RNA Biopesticide Business (2021–2026)
11.4.5 RNAissance Ag Recent Development
11.5 Pebble Labs
11.5.1 Pebble Labs Company Details
11.5.2 Pebble Labs Business Overview
11.5.3 Pebble Labs RNA Biopesticide Introduction
11.5.4 Pebble Labs Revenue in RNA Biopesticide Business (2021–2026)
11.5.5 Pebble Labs Recent Development
11.6 Renaissance BioScience
11.6.1 Renaissance BioScience Company Details
11.6.2 Renaissance BioScience Business Overview
11.6.3 Renaissance BioScience RNA Biopesticide Introduction
11.6.4 Renaissance BioScience Revenue in RNA Biopesticide Business (2021–2026)
11.6.5 Renaissance BioScience Recent Development
11.7 Silicon Gene
11.7.1 Silicon Gene Company Details
11.7.2 Silicon Gene Business Overview
11.7.3 Silicon Gene RNA Biopesticide Introduction
11.7.4 Silicon Gene Revenue in RNA Biopesticide Business (2021–2026)
11.7.5 Silicon Gene Recent Development
11.8 Shanghai Plant Science Biotechnology
11.8.1 Shanghai Plant Science Biotechnology Company Details
11.8.2 Shanghai Plant Science Biotechnology Business Overview
11.8.3 Shanghai Plant Science Biotechnology RNA Biopesticide Introduction
11.8.4 Shanghai Plant Science Biotechnology Revenue in RNA Biopesticide Business (2021–2026)
11.8.5 Shanghai Plant Science Biotechnology Recent Development
11.9 Xiaomo Biotech
11.9.1 Xiaomo Biotech Company Details
11.9.2 Xiaomo Biotech Business Overview
11.9.3 Xiaomo Biotech RNA Biopesticide Introduction
11.9.4 Xiaomo Biotech Revenue in RNA Biopesticide Business (2021–2026)
11.9.5 Xiaomo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNA Biopesticide Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of PIP
Table 3. Key Players of Non-PIP
Table 4. Global RNA Biopesticide Market Size Growth Rate by Target Organism (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Insect Pests
Table 6. Key Players of Nematodes and Mites
Table 7. Key Players of Pathogens
Table 8. Key Players of Other
Table 9. Global RNA Biopesticide Market Size Growth Rate by Crop (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Potatoes
Table 11. Key Players of Corn
Table 12. Key Players of Other
Table 13. Global RNA Biopesticide Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global RNA Biopesticide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global RNA Biopesticide Market Size by Region (US$ Million), 2021–2026
Table 16. Global RNA Biopesticide Market Share by Region (2021–2026)
Table 17. Global RNA Biopesticide Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global RNA Biopesticide Market Share by Region (2027–2032)
Table 19. RNA Biopesticide Market Trends
Table 20. RNA Biopesticide Market Drivers
Table 21. RNA Biopesticide Market Challenges
Table 22. RNA Biopesticide Market Restraints
Table 23. Global RNA Biopesticide Revenue by Players (US$ Million), 2021–2026
Table 24. Global RNA Biopesticide Market Share by Players (2021–2026)
Table 25. Global Top RNA Biopesticide Players by Tier (Tier 1, Tier 2, and Tier 3), based on RNA Biopesticide Revenue, 2025
Table 26. Ranking of Global Top RNA Biopesticide Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by RNA Biopesticide Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of RNA Biopesticide, Headquarters and Area Served
Table 29. Global Key Players of RNA Biopesticide, Products and Applications
Table 30. Global Key Players of RNA Biopesticide, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global RNA Biopesticide Market Size by Type (US$ Million), 2021–2026
Table 33. Global RNA Biopesticide Revenue Market Share by Type (2021–2026)
Table 34. Global RNA Biopesticide Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global RNA Biopesticide Revenue Market Share by Type (2027–2032)
Table 36. Global RNA Biopesticide Market Size by Application (US$ Million), 2021–2026
Table 37. Global RNA Biopesticide Revenue Market Share by Application (2021–2026)
Table 38. Global RNA Biopesticide Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global RNA Biopesticide Revenue Market Share by Application (2027–2032)
Table 40. North America RNA Biopesticide Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America RNA Biopesticide Market Size by Country (US$ Million), 2021–2026
Table 42. North America RNA Biopesticide Market Size by Country (US$ Million), 2027–2032
Table 43. Europe RNA Biopesticide Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe RNA Biopesticide Market Size by Country (US$ Million), 2021–2026
Table 45. Europe RNA Biopesticide Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific RNA Biopesticide Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific RNA Biopesticide Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific RNA Biopesticide Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America RNA Biopesticide Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America RNA Biopesticide Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America RNA Biopesticide Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa RNA Biopesticide Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa RNA Biopesticide Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa RNA Biopesticide Market Size by Country (US$ Million), 2027–2032
Table 55. Bayer Company Details
Table 56. Bayer Business Overview
Table 57. Bayer RNA Biopesticide Product
Table 58. Bayer Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 59. Bayer Recent Development
Table 60. Corteva Company Details
Table 61. Corteva Business Overview
Table 62. Corteva RNA Biopesticide Product
Table 63. Corteva Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 64. Corteva Recent Development
Table 65. Greenlight Biosciences Company Details
Table 66. Greenlight Biosciences Business Overview
Table 67. Greenlight Biosciences RNA Biopesticide Product
Table 68. Greenlight Biosciences Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 69. Greenlight Biosciences Recent Development
Table 70. RNAissance Ag Company Details
Table 71. RNAissance Ag Business Overview
Table 72. RNAissance Ag RNA Biopesticide Product
Table 73. RNAissance Ag Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 74. RNAissance Ag Recent Development
Table 75. Pebble Labs Company Details
Table 76. Pebble Labs Business Overview
Table 77. Pebble Labs RNA Biopesticide Product
Table 78. Pebble Labs Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 79. Pebble Labs Recent Development
Table 80. Renaissance BioScience Company Details
Table 81. Renaissance BioScience Business Overview
Table 82. Renaissance BioScience RNA Biopesticide Product
Table 83. Renaissance BioScience Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 84. Renaissance BioScience Recent Development
Table 85. Silicon Gene Company Details
Table 86. Silicon Gene Business Overview
Table 87. Silicon Gene RNA Biopesticide Product
Table 88. Silicon Gene Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 89. Silicon Gene Recent Development
Table 90. Shanghai Plant Science Biotechnology Company Details
Table 91. Shanghai Plant Science Biotechnology Business Overview
Table 92. Shanghai Plant Science Biotechnology RNA Biopesticide Product
Table 93. Shanghai Plant Science Biotechnology Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 94. Shanghai Plant Science Biotechnology Recent Development
Table 95. Xiaomo Biotech Company Details
Table 96. Xiaomo Biotech Business Overview
Table 97. Xiaomo Biotech RNA Biopesticide Product
Table 98. Xiaomo Biotech Revenue in RNA Biopesticide Business (US$ Million), 2021–2026
Table 99. Xiaomo Biotech Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. RNA Biopesticide Picture
Figure 2. Global RNA Biopesticide Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global RNA Biopesticide Market Share by Type: 2025 vs 2032
Figure 4. PIP Features
Figure 5. Non-PIP Features
Figure 6. Global RNA Biopesticide Market Size Comparison by Target Organism (US$ Million), 2021–2032
Figure 7. Insect Pests Features
Figure 8. Nematodes and Mites Features
Figure 9. Pathogens Features
Figure 10. Other Features
Figure 11. Global RNA Biopesticide Market Size Comparison by Crop (US$ Million), 2021–2032
Figure 12. Potatoes Features
Figure 13. Corn Features
Figure 14. Other Features
Figure 15. Global RNA Biopesticide Market Size by Application (US$ Million), 2021–2032
Figure 16. Global RNA Biopesticide Market Share by Application: 2025 vs 2032
Figure 17. Farmland Case Studies
Figure 18. Orchard Case Studies
Figure 19. Other Case Studies
Figure 20. RNA Biopesticide Report Years Considered
Figure 21. Global RNA Biopesticide Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global RNA Biopesticide Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global RNA Biopesticide Market Share by Region: 2025 vs 2032
Figure 24. Global RNA Biopesticide Market Share by Players in 2025
Figure 25. Global RNA Biopesticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by RNA Biopesticide Revenue in 2025
Figure 27. North America RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America RNA Biopesticide Market Share by Country (2021–2032)
Figure 29. United States RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe RNA Biopesticide Market Share by Country (2021–2032)
Figure 33. Germany RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific RNA Biopesticide Market Share by Region (2021–2032)
Figure 41. China RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America RNA Biopesticide Market Share by Country (2021–2032)
Figure 49. Mexico RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa RNA Biopesticide Market Share by Country (2021–2032)
Figure 53. Israel RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE RNA Biopesticide Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Bayer Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 57. Corteva Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 58. Greenlight Biosciences Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 59. RNAissance Ag Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 60. Pebble Labs Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 61. Renaissance BioScience Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 62. Silicon Gene Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 63. Shanghai Plant Science Biotechnology Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 64. Xiaomo Biotech Revenue Growth Rate in RNA Biopesticide Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
